Nicox SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nicox SA with three other
pharmaceutical manufacturers in Europe:
Arcticzymes Technologies ASA
sales of 77.25 million Norwegian Kroner [US$8.75 million]
of which 59%
Marinomed Biotech AG
(6.14 million Euros [US$7.33 million]
of which 100%
was Carragelose), and
based in RUSSIAN FEDERATION
(657.75 million Russian Rubles [US$8.65 million]
During the year ended December of 2019, sales at
Nicox SA were 6.86 million Euro (US$8.18 million).
increase of 70.2%
versus 2018, when the company's sales were 4.03 million Euro.
This was the third consecutive year of growth at Nicox SA.